Annual Total Assets
$97.55 M
-$55.35 M-36.20%
December 31, 2023
Summary
- As of February 26, 2025, RLMD annual total assets is $97.55 million, with the most recent change of -$55.35 million (-36.20%) on December 31, 2023.
- During the last 3 years, RLMD annual total assets has fallen by -$20.63 million (-17.46%).
- RLMD annual total assets is now -56.32% below its all-time high of $223.33 million, reached on December 31, 2021.
Performance
RLMD Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$55.72 M
-$15.30 M-21.55%
September 30, 2024
Summary
- As of February 26, 2025, RLMD quarterly total assets is $55.72 million, with the most recent change of -$15.30 million (-21.55%) on September 30, 2024.
- Over the past year, RLMD quarterly total assets has dropped by -$28.68 million (-33.98%).
- RLMD quarterly total assets is now -75.32% below its all-time high of $225.81 million, reached on March 31, 2022.
Performance
RLMD Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
RLMD Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -36.2% | -34.0% |
3 y3 years | -17.5% | -38.7% |
5 y5 years | +854.5% | +554.5% |
RLMD Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -56.3% | at low | -75.3% | at low |
5 y | 5-year | -56.3% | at low | -75.3% | +554.5% |
alltime | all time | -56.3% | >+9999.0% | -75.3% | >+9999.0% |
Relmada Therapeutics Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $55.72 M(-21.5%) |
Jun 2024 | - | $71.03 M(-15.9%) |
Mar 2024 | - | $84.41 M(-13.5%) |
Dec 2023 | $97.55 M(-36.2%) | $97.55 M(-10.6%) |
Sep 2023 | - | $109.15 M(-10.6%) |
Jun 2023 | - | $122.04 M(-10.0%) |
Mar 2023 | - | $135.57 M(-11.3%) |
Dec 2022 | $152.91 M(-31.5%) | $152.91 M(-18.3%) |
Sep 2022 | - | $187.12 M(-13.3%) |
Jun 2022 | - | $215.77 M(-4.4%) |
Mar 2022 | - | $225.81 M(+1.1%) |
Dec 2021 | $223.33 M(+89.0%) | $223.33 M(+145.6%) |
Sep 2021 | - | $90.93 M(-17.9%) |
Jun 2021 | - | $110.77 M(+6.6%) |
Mar 2021 | - | $103.87 M(-12.1%) |
Dec 2020 | $118.19 M(+0.9%) | $118.19 M(-5.9%) |
Sep 2020 | - | $125.60 M(-6.7%) |
Jun 2020 | - | $134.56 M(+16.6%) |
Mar 2020 | - | $115.42 M(+1255.6%) |
Dec 2019 | $117.14 M(+1046.2%) | - |
Sep 2019 | - | $8.51 M(-16.7%) |
Jun 2019 | $10.22 M | $10.22 M(+292.5%) |
Mar 2019 | - | $2.60 M(-21.1%) |
Dec 2018 | - | $3.30 M(+112.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2018 | - | $1.56 M(-49.0%) |
Jun 2018 | $3.05 M(+7.4%) | $3.05 M(-36.4%) |
Mar 2018 | - | $4.80 M(-27.0%) |
Dec 2017 | - | $6.57 M(+17.1%) |
Sep 2017 | - | $5.61 M(+97.9%) |
Jun 2017 | $2.84 M(-72.3%) | $2.84 M(-32.0%) |
Mar 2017 | - | $4.17 M(-33.0%) |
Dec 2016 | - | $6.23 M(-21.4%) |
Sep 2016 | - | $7.92 M(-22.7%) |
Jun 2016 | $10.24 M(-58.0%) | $10.24 M(-19.5%) |
Mar 2016 | - | $12.72 M(-23.4%) |
Dec 2015 | - | $16.60 M(-18.9%) |
Sep 2015 | - | $20.48 M(-16.0%) |
Jun 2015 | $24.39 M(-5.3%) | $24.39 M(-12.4%) |
Mar 2015 | - | $27.85 M(-15.1%) |
Dec 2014 | - | $32.79 M(+17.8%) |
Sep 2014 | - | $27.85 M(>+9900.0%) |
Jun 2014 | $25.76 M(>+9900.0%) | - |
Feb 2014 | - | $10.00 K(-18.7%) |
Nov 2013 | - | $12.30 K(-38.5%) |
Aug 2013 | $20.00 K(+8.7%) | $20.00 K(+325.5%) |
May 2013 | - | $4700.00(-53.9%) |
Feb 2013 | - | $10.20 K(-44.6%) |
Aug 2012 | $18.40 K | $18.40 K |
FAQ
- What is Relmada Therapeutics annual total assets?
- What is the all time high annual total assets for Relmada Therapeutics?
- What is Relmada Therapeutics annual total assets year-on-year change?
- What is Relmada Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly total assets year-on-year change?
What is Relmada Therapeutics annual total assets?
The current annual total assets of RLMD is $97.55 M
What is the all time high annual total assets for Relmada Therapeutics?
Relmada Therapeutics all-time high annual total assets is $223.33 M
What is Relmada Therapeutics annual total assets year-on-year change?
Over the past year, RLMD annual total assets has changed by -$55.35 M (-36.20%)
What is Relmada Therapeutics quarterly total assets?
The current quarterly total assets of RLMD is $55.72 M
What is the all time high quarterly total assets for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly total assets is $225.81 M
What is Relmada Therapeutics quarterly total assets year-on-year change?
Over the past year, RLMD quarterly total assets has changed by -$28.68 M (-33.98%)